Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Syk deficiency significantly enhanced ceramide-induced apoptosis. Ectopic expression of wild-type or kinase-inactive Syk rendered Syk-negative cells resistant to ceramide-induced apoptosis. Furthermore, ceramide could not activate Syk, indicating that Syk protected DT40 cells from ceramide-induced apoptosis, via a mechanism independent of its activity. In addition, a deficiency in Lyn also resulted in the cells becoming susceptible to ceramide-induced apoptosis. However, no difference of
Ara-C
-induced apoptosis between wild-type and mutant cells was observed.
c-Jun
N-terminal kinases appeared not to be important in mediating the enhanced apoptosis, as they were still activated in mutant cells following ceramide treatment.
...
PMID:A deficiency in Syk enhances ceramide-induced apoptosis in DT40 lymphoma B cells. 961 15
Neurotoxicity is one of the side-effects of the therapeutically useful antitumour agent,
Ara-C
(or 1-beta-d-arabinofuranosyl-cytosine, cytarabine). This agent is also reported to induce cell death of cultured neurons. In this study, we show that
Ara-C
-induced death of differentiating rat cerebellar granule neurons is prevented by cycloheximide at concentrations corresponding to its action in preventing protein synthesis. The death is accompanied by cleavage of the caspase substrate poly ADP ribose polymerase (PARP) and c-Abl-dependent activation of the stress-activated protein kinases c-Jun N-terminal kinase and p38. However,
c-Jun
levels do not rise and the activation of the stress-activated protein kinases is not required for this form of neuronal death. Cyclin-dependent kinase (cdk) activity and inappropriate cell-cycle re-entry have been implicated in some forms of death in differentiated neurons. Here we show that
Ara-C
-induced death of cerebellar granule neurons is prevented by an inhibitor of cdk4, whereas inhibition of cdk1, -2 and -5 mimics the death, and non-cdk4/6 cdks are inhibited by
Ara-C
treatment. Cdk1 and -2 are dramatically down-regulated during neuronal differentiation, and neither
Ara-C
nor inhibition of these cdks induces death in mature neurons. This mechanism could also play a significant role in the neurotoxicity associated with the therapeutic use of
Ara-C
, as cdk levels can be upregulated in stressed neurons of adult brain. We propose that the balance between cdk4/6 and cdk1/2/5 activity may determine the survival of early differentiating neurons, and that DNA-damaging agents may induce neuronal death by inhibiting cdk1/2/5 under conditions which require these activities for survival.
...
PMID:The mechanism of Ara-C-induced apoptosis of differentiating cerebellar granule neurons. 1010
Activation of the JNK pathway and induction of the AP-1 transcription factor
c-Jun
are critical for neuronal apoptosis caused by a variety of insults.
Ara-C
-induced DNA damage caused rapid sympathetic neuronal death that was associated with an increase of c-jun expression. In addition,
c-Jun
was phosphorylated in its N-terminal transactivation domain, which is important for
c-Jun
-mediated gene transcription. Blocking
c-Jun
activation by JNK pathway inhibition prevented neuronal death after stress. In contrast, neither the JNK inhibitor SP600125 nor the mixed lineage kinase inhibitor CEP-1347 prevented cytosine arabinoside-induced neuronal death, demonstrating that the JNK pathway was not necessary for DNA damage-induced neuronal apoptosis. Surprisingly, SP600125 or CEP-1347 could not block
c-Jun
induction or phosphorylation after DNA damage. Pharmacological inhibitors of cyclin-dependent kinase (CDK) activity completely prevented
c-Jun
phosphorylation after DNA damage. These results demonstrate that
c-Jun
activation during DNA damage-induced neuronal apoptosis was independent of the classical JNK pathway and was mediated by a novel
c-Jun
kinase. Based on pharmacological criteria, DNA damage-induced neuronal
c-Jun
kinase may be a member of the CDK family or be activated by a CDK-like kinase. Activation of this novel kinase and subsequent phosphorylation of
c-Jun
may be important in neuronal death after DNA damage.
...
PMID:JNK-independent activation of c-Jun during neuronal apoptosis induced by multiple DNA-damaging agents. 1268 20